Disease Info Card

Malignant Neoplasm Of Skin

Information about Malignant Neoplasm Of Skin: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Malignant Neoplasm Of Skin

Most recent studies have shown that Malignant Neoplasm Of Skin shares some biological mechanisms with actinic-keratosis, basal-cell-carcinoma, carcinogenesis, carcinoma, cutaneous-melanoma, decreased-immunologic-activity-[pe], dermatologic-disorders, keratosis, lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-squamous-cell-neoplasm, melanoma, neoplasm-metastasis, neoplasms, neoplasms-radiation-induced, skin-carcinoma, skin-neoplasms, sunburn, xeroderma-pigmentosum.

Among the many pathways, these few ones have gauged particular interests from scientists studying Malignant Neoplasm Of Skin, and have been seen in publications frequently: Aging, Angiogenesis, Cell Cycle, Cell Cycle Arrest, Cell Death, Cell Growth, Cell Proliferation, Dna Repair, Hypersensitivity, Immune Response, Induction Of Apoptosis, Inflammatory Response, Localization, Methylation, Pathogenesis, Photoprotection, Pigmentation, Secretion, Uv Protection, Wound Healing

Quite a number of genes have been found to play important roles in Malignant Neoplasm Of Skin, such as AKT1, BCL2, CASP3, CDKN1A, CDKN2A, EGFR, ERCC2, FOS, JUN, MAPK1, PCNA, POLH, POMC, PTGS2, SERPINB3, TNF, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.